By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Interleukin inhibitors > Spevigo > Spevigo Side Effects
Interleukin inhibitors

Spevigo Side Effects

Note: This document contains side effect information about spesolimab. Some dosage forms listed on this page may not apply to the brand name Spevigo.

Applies to spesolimab: intravenous solution.

Serious side effects of Spevigo

Along with its needed effects, spesolimab (the active ingredient contained in Spevigo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking spesolimab:

More common

  • Bladder pain
  • bloody or cloudy urine
  • difficult, burning, or painful urination
  • frequent urge to urinate
  • large, flat, blue, or purplish patches in the skin
  • lower back or side pain

Less common

  • Blistering, crusting, irritation, itching, or reddening of the skin
  • bruising at the injection site
  • body aches or pain
  • chest pain
  • chills
  • cough
  • coughing or spitting up blood
  • ear congestion
  • fever
  • headache
  • itching of the vagina or genitals
  • loss of voice
  • muscle aches
  • night sweats
  • sneezing
  • sore throat
  • stuffy or runny nose
  • sudden high fever or low-grade fever for months
  • swelling
  • thick, white vaginal discharge with mild or no odor
  • trouble breathing
  • unusual tiredness or weakness

Incidence not known

  • Black, tarry stools
  • bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
  • inability to move the arms and legs
  • painful or difficult urination
  • sores, ulcers, or white spots on the lips or in the mouth
  • sudden numbness and weakness in the arms and legs
  • swollen glands
  • unusual bleeding or bruising

Other side effects of Spevigo

Some side effects of spesolimab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Change in hearing
  • diarrhea
  • earache
  • ear drainage
  • itching ears
  • lack or loss of strength
  • nausea
  • vomiting

Less common

  • Hives, itching, or skin rash
  • swelling of the eye

For Healthcare Professionals

Applies to spesolimab: intravenous solution.

Dermatologic

Common (1% to 10%): Cellulitis, furuncle, herpes dermatitis, pruritus and prurigo, subcutaneous abscess, urticaria[Ref]

Two patients experienced drug reaction with eosinophilia and systemic symptoms (DRESS). The validation scoring for reported cases were "no DRESS" and "possible DRESS".[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (11%)

Common (1% to 10%): Gastritis, nausea and vomiting, oral herpes[Ref]

General

The most common adverse effects were infections. Infection occurred in 14% of patients during the first week of treatment as compared to 6% in the placebo group. The majority of infections reported were mild (29%) to moderate (71%).[Ref]

Genitourinary

Common (1% to 10%): Bacteriuria, urinary tract infection, vulvovaginal candidiasis, vulvovaginal mycotic infection[Ref]

Local

Common (1% to 10%): Infusion site hematoma and bruising

Not reported: Injection site reactions[Ref]

During clinical trials, injection site reactions (including injection site erythema, injection site swelling, injection site pain, injection site induration, and injection site warmth) were observed.[Ref]

Nervous system

Common (1% to 10%): Headache

Uncommon (0.1% to 1%): Guillain-Barre syndrome[Ref]

Ocular

Common (1% to 10%): Eye edema[Ref]

Other

Common (1% to 10%): Asthenia and fatigue, bacteremia, device-related infection, otitis externa[Ref]

Respiratory

Common (1% to 10%): Dyspnea, influenza, latent tuberculosis, upper respiratory tract infection[Ref]

Share this Article
Latest News
Medical News

Liver disease: Diabetes and weight loss drug may be effective

May 13, 2025
Alzheimer's: HIV drugs may offer ‘significant’ protection
Gastrointestinal cancer: Can eating chicken shorten lifespan?
Shingles vaccine may lower heart disease risk by up to 8 years
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by